Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
QLIFE.ST Stock Summary
In the News
QLIFE.ST Financial details
Company Rating
Buy
Market Cap
34.07M
Income
-93.14M
Revenue
17.99M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
62
Optionable
No
Shortable
Yes
Earnings
05 May 2021
P/E
-0.27
Forward P/E
-
PEG
0.2
P/S
1.89
P/B
0.27
P/C
-
P/FCF
-0.41
Quick Ratio
0.27
Current Ratio
0.75
Debt / Equity
1.11
LT Debt / Equity
0.53
-
-
EPS (TTM)
-0.85
EPS next Y
-
EPS next Q
-
EPS this Y
42.86%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-44.28%
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-48%
ROE
-96%
ROC
-0.69%
Gross Margin
-60%
Oper. Margin
-532%
Profit Margin
-518%
Payout
-
Shs Outstand
89.78M
Shs Float
21.37M
-
-
-
-
Target Price
-
52W Range
0.080567-24.6
52W High
-
52W Low
-
RSI
44
Rel Volume
3.89
Avg Volume
496.55K
Volume
1.93M
Perf Week
90.9%
Perf Month
-17.5%
Perf Quarter
-81.44%
Perf Half Y
-85.4%
-
-
-
-
Beta
0.734654
-
-
Volatility
0.06%, 0.06%
Prev Close
69.04%
Price
0.3795
Change
67.18%
QLIFE.ST Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|
Revenue per share | 0 | 0.42 | 0.8 | 0.27 | |
Net income per share | 0 | -0.41 | -0.98 | -1.4 | |
Operating cash flow per share | 0 | -0.34 | -0.52 | -0.72 | |
Free cash flow per share | 0 | -0.89 | -1.06 | -1.37 | |
Cash per share | 0 | 0.42 | 1.48 | 0.22 | |
Book value per share | 0 | 1.82 | 3.28 | 1.37 | |
Tangible book value per share | 0 | 0.26 | 1.53 | -0.1 | |
Share holders equity per share | 0 | 1.82 | 3.28 | 1.37 | |
Interest debt per share | 0 | 0.09 | 0.1 | 0.86 | |
Market cap | 0 | 1.14B | 1.66B | 132.68M | |
Enterprise value | 146.67K | 1.13B | 1.59B | 170.57M | |
P/E ratio | 0 | -56.66 | -33.92 | -1.42 | |
Price to sales ratio | 0 | 55.15 | 41.82 | 7.37 | |
POCF ratio | 0 | -68 | -63.6 | -2.78 | |
PFCF ratio | 0 | -26.21 | -31.37 | -1.46 | |
P/B Ratio | 0 | 12.78 | 10.15 | 1.46 | |
PTB ratio | 0 | 12.78 | 10.15 | 1.46 | |
EV to sales | 0 | 54.34 | 40.06 | 9.48 | |
Enterprise value over EBITDA | 0 | -58.06 | -44.76 | -2.19 | |
EV to operating cash flow | 0 | -67 | -60.92 | -3.57 | |
EV to free cash flow | 0 | -25.83 | -30.05 | -1.88 | |
Earnings yield | 0 | -0.02 | -0.03 | -0.7 | |
Free cash flow yield | 0 | -0.04 | -0.03 | -0.68 | |
Debt to equity | 0.23 | 0.42 | 0.19 | 1.11 | |
Debt to assets | 0.18 | 0.3 | 0.16 | 0.53 | |
Net debt to EBITDA | 0 | 0.87 | 1.97 | -0.49 | |
Current ratio | 0.79 | 1.32 | 3.7 | 0.75 | |
Interest coverage | 0 | -50.93 | -39.08 | -19.61 | |
Income quality | 0 | 0.53 | 0.46 | 0.47 | |
Dividend Yield | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 1.49 | 1.01 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | -2.59 | |
Intangibles to total assets | 0.88 | 0.6 | 0.45 | 0.51 | |
Capex to operating cash flow | 0 | 1.59 | 1.03 | 0.9 | |
Capex to revenue | 0 | -1.29 | -0.68 | -2.39 | |
Capex to depreciation | 0 | 0 | 0 | -2.38 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | |
Graham number | 0 | 4.09 | 8.52 | 6.58 | |
ROIC | 0 | -0.27 | -1.3 | -0.62 | |
Return on tangible assets | 0 | -0.4 | -0.46 | -0.98 | |
Graham Net | 0 | -0.29 | 0.95 | -1.25 | |
Working capital | -2.04M | 10.95M | 74.28M | -13.21M | |
Tangible asset value | -5.18M | 12.68M | 75.81M | -6.64M | |
Net current asset value | -6.23M | 7.52M | 71.51M | -61.51M | |
Invested capital | 0.07 | 0.04 | 0.02 | 0.58 | |
Average receivables | 0 | 0 | 0 | 0 | |
Average payables | 0 | 6.88M | 10.82M | 15.06M | |
Average inventory | 0 | 3.83M | 6.84M | 8.19M | |
Days sales outstanding | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | -283.7 | -742.67 | 255.08 | |
Days of inventory on hand | 0 | -131.43 | -615.42 | 102.48 | |
Receivables turnover | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | -1.29 | -0.49 | 1.43 | |
Inventory turnover | 0 | -2.78 | -0.59 | 3.56 | |
ROE | 0 | -0.23 | -0.3 | -1.02 | |
Capex per share | 0 | -0.54 | -0.54 | -0.65 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q4
Metric | History | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 0.11 | 0.16 | 0.06 | 0.03 | 0 | |
Net income per share | -0.15 | -0.22 | -0.29 | -0.34 | 0 | |
Operating cash flow per share | -0.01 | -0.3 | -0.08 | -0.24 | 0 | |
Free cash flow per share | -0.09 | -0.45 | -0.26 | -1.26 | 0 | |
Cash per share | 0.7 | 0.63 | 0.5 | 0.19 | 0 | |
Book value per share | 1.55 | 1.72 | 1.44 | 1.32 | 0 | |
Tangible book value per share | 0.72 | 0.79 | 0.31 | -0.17 | 0 | |
Share holders equity per share | 1.55 | 1.72 | 1.44 | 1.32 | 0 | |
Interest debt per share | 0.03 | 0.06 | 0.85 | 1.13 | 0 | |
Market cap | 3.51B | 1.36B | 813.46M | 631.46M | 0 | |
Enterprise value | 3.44B | 1.32B | 837.47M | 690.47M | 37.89M | |
P/E ratio | -54.37 | -22.21 | -10.09 | -7.63 | 0 | |
Price to sales ratio | 290.38 | 124.37 | 202.1 | 321.03 | 0 | |
POCF ratio | -4.56K | -67.22 | -144.87 | -44.41 | 0 | |
PFCF ratio | -391.58 | -44.52 | -45.41 | -8.29 | 0 | |
P/B Ratio | 21.5 | 11.52 | 8.24 | 7.95 | 0 | |
PTB ratio | 21.5 | 11.52 | 8.24 | 7.95 | 0 | |
EV to sales | 284.61 | 120.83 | 208.07 | 351.03 | 34.57 | |
Enterprise value over EBITDA | -288.4 | -80.86 | -40.61 | -46.5 | -1.44 | |
EV to operating cash flow | -4.47K | -65.31 | -149.15 | -48.56 | -4.91 | |
EV to free cash flow | -383.8 | -43.25 | -46.75 | -9.06 | 0.91 | |
Earnings yield | 0 | -0.01 | -0.02 | -0.03 | 0 | |
Free cash flow yield | 0 | -0.02 | -0.02 | -0.12 | 0 | |
Debt to equity | 0.19 | 0.25 | 1.08 | 1.54 | 1.11 | |
Debt to assets | 0.16 | 0.2 | 0.52 | 0.61 | 0.53 | |
Net debt to EBITDA | 5.85 | 2.37 | -1.16 | -3.97 | -1.44 | |
Current ratio | 3.7 | 3.13 | 1.28 | 0.77 | 0.75 | |
Interest coverage | 71.73 | 78.9 | 879.78 | 8.63 | -13.92 | |
Income quality | 0.04 | 1.04 | 0.24 | 0.69 | 0.21 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.85 | 1.13 | 3.76 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.45 | 0.43 | 0.38 | 0.45 | 0.51 | |
Capex to operating cash flow | 10.65 | 0.51 | 2.19 | 4.36 | -6.41 | |
Capex to revenue | -0.68 | -0.94 | -3.06 | -31.5 | 45.2 | |
Capex to depreciation | 0 | -3.68 | -3.93 | -16.69 | 5.91 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.31 | 2.94 | 3.09 | 3.19 | 0 | |
ROIC | -0.43 | -0.29 | -0.17 | -0.12 | -0.24 | |
Return on tangible assets | -0.15 | -0.18 | -0.16 | -0.18 | -0.39 | |
Graham Net | 0.47 | 0.29 | -0.96 | -1.68 | 0 | |
Working capital | 74.28M | 53.63M | 16.18M | -16.45M | -13.21M | |
Tangible asset value | 75.81M | 53.85M | 21.04M | -10.38M | -6.64M | |
Net current asset value | 71.51M | 49.17M | -32.07M | -65.72M | -61.51M | |
Invested capital | 0.02 | 0.04 | 0.59 | 0.88 | 0.58 | |
Average receivables | 1.38M | 2M | 892K | 449.5K | 184.5K | |
Average payables | 9.88M | 9.28M | 12.08M | 17.59M | 19.83M | |
Average inventory | 8.9M | 9.97M | 12.15M | 15.63M | 13.33M | |
Days sales outstanding | 20.52 | 10.35 | 11.85 | 16.88 | 0 | |
Days payables outstanding | -55.87 | -876.5 | -165.31 | -157.91 | 36.69 | |
Days of inventory on hand | -46.3 | -1.19K | -134.06 | -150.06 | 14.74 | |
Receivables turnover | 4.39 | 8.7 | 7.59 | 5.33 | 0 | |
Payables turnover | -1.61 | -0.1 | -0.54 | -0.57 | 2.45 | |
Inventory turnover | -1.94 | -0.08 | -0.67 | -0.6 | 6.11 | |
ROE | -0.1 | -0.13 | -0.2 | -0.26 | -0.41 | |
Capex per share | -0.08 | -0.15 | -0.18 | -1.03 | 0 |
QLIFE.ST Frequently Asked Questions
What is Qlife Holding AB (publ) stock symbol ?
Qlife Holding AB (publ) is a SE stock and trading under the symbol QLIFE.ST
What is Qlife Holding AB (publ) stock quote today ?
Qlife Holding AB (publ) stock price is $0.3795 today.
Is Qlife Holding AB (publ) stock public?
Yes, Qlife Holding AB (publ) is a publicly traded company.